SCHEMBL1477529

SCHEMBL1477529

N[C@@H]1C[C@@H]1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14834725 1.00
SCHEMBL9491253 1.00
SCHEMBL12586319 1.00
SCHEMBL1897712 1.00
SCHEMBL2084660 1.00
SCHEMBL21570199 1.00
Hydrochloric Acid SCHEMBL23548989 0.95
Hydrochloric Acid SCHEMBL9095531 0.95
Hydrochloric Acid SCHEMBL9095529 0.95
Hydrochloric Acid SCHEMBL12986435 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036535-A Antibacterial sitafloxacin preparation method of star intermediate 惠州信立泰药业有限公司 2026-05-15 CN claimed
CN-116265467-B Intermediate for synthesizing TYK2 inhibitor, and preparation method and application thereof 成都科岭源医药技术有限公司 2025-04-18 CN claimed
EP-2867227-B1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2018-11-21 EP claimed
US-9487483-B2 Complement pathway modulators and uses thereof NOVARTIS AG (CH) 2016-11-08 US claimed
US-20150148349-A1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2015-05-28 US claimed
EP-2867227-A2 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF Novartis AG (CH) 2015-05-06 EP claimed
WO-2014002058-A2 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2014-01-03 WO claimed
US-7915418-B2 Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2011-03-29 US claimed
US-20100069435-A1 METHOD OF SELECTIVELY INTRODUCING AMINO SUBSTITUENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2010-03-18 US claimed
US-7626029-B2 Into a difluorobenzoic acid, for producting quinolonecarboxylic acid serving as synthetic antibacterial agent, medicament, agricultural chemical, or veterinary drug; ionic liquid solvents DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-12-01 US claimed
US-20060135775-A1 Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-06-22 US claimed
US-20060122396-A1 Method of selectively introducing amino substituent DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-06-08 US claimed
EP-1634879-A1 METHOD OF SELECTIVELY INTRODUCING AMINO SUBSTITUENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-03-15 EP claimed
EP-1632482-A1 INTERMEDIATES AND PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE QUINOLONECARBOXYLIC ACID DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-03-08 EP claimed
JP-5163211-A None JP disclosed
JP-4327580-A None JP disclosed
JP-7316104-A None JP disclosed
JP-H04327580-A 3-SUBSTITUTED OXAZOLIDINONE DERIVATIVE AND ITS PRODUCTION DAI ICHI SEIYAKU CO LTD 1992-11-17 JP disclosed
CN-1037507-A Optically active pyridone carboxylic acid derivatives DAIICHI SEIYAKU CO (JP) 1989-11-29 CN disclosed
EP-0341493-A2 Optically active pyridonecarboxylic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1989-11-15 EP disclosed